[1]陈佳永,庞 延,潘朝锌,等.基于心肌能量代谢探讨中医药防治心力衰竭研究进展[J].陕西中医,2024,(7):1002-1005.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.032]
 CHEN Jiayong,PANG Yan,PAN Chaoxin,et al.Research progress of traditional Chinese medicine in prevention and treatment of heart failure based on myocardial energy metabolism[J].,2024,(7):1002-1005.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.032]
点击复制

基于心肌能量代谢探讨中医药防治心力衰竭研究进展
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年7期
页码:
1002-1005
栏目:
综 述
出版日期:
2024-07-05

文章信息/Info

Title:
Research progress of traditional Chinese medicine in prevention and treatment of heart failure based on myocardial energy metabolism
作者:
陈佳永1庞 延2潘朝锌2卢健棋2
(1.广西中医药大学研究生院,广西 南宁 530200; 2.广西中医药大学第一附属医院,广西 南宁 530022)
Author(s):
CHEN JiayongPANG YanPAN ChaoxinLU Jianqi
(Graduate School of Guangxi University of Traditional Chinese Medicine,Nanning 530200,China)
关键词:
心力衰竭 线粒体 能量代谢 补气活血 温阳利水 祛痰平喘 益气养阴
Keywords:
Heart failure Mitochondria Energy metabolism Buqi Huoxue Wenyang Lishui Qutan Pingchuan Yiqi Yangyin
分类号:
R 541.6
DOI:
DOI:10.3969/j.issn.1000-7369.2024.07.032
文献标志码:
A
摘要:
心力衰竭(HF)是各种心血管疾病发展的终末期。即使近年来现代医学在HF治疗方面取得了巨大进展,但HF的住院率、病死率仍然居高不下。随着2022年心力衰竭管理指南的更新, HF治疗从传统的“金三角”踏入了崭新的“新四联”治疗时代,提示心肌能量改善HF预后的重要地位。而中医药治疗HF具有多靶点、多通路、不良反应小等优势,在HF心肌能量代谢中同样具有重要治疗作用,本文通过总结梳理中医药在心肌能量代谢中治疗心力衰竭的作用机制,为HF提供新的治疗思路。
Abstract:
Heart failure(HF)is the end stage of development of various cardiovascular diseases.Although modern medicine has made great progress in treatment of HF in recent years,hospitalization rate and mortality rate of HF remain high.With the update of heart failure management guidelines in 2022,HF from the traditional golden triangle entered new new quadruple treatment era.It is suggested that myocardial energy plays an important role in improving the prognosis of HF.The treatment of HF with traditional Chinese medicine has advantages of multi-target,multi-pathway and small side effects,and also plays an important role in the treatment of HF myocardial energy metabolism.The paper summarizes mechanism of traditional Chinese medicine in treatment of heart failure in myocardial energy metabolism,in order to provide new treatment ideas for HF.

参考文献/References:

[1] LOPASCHUK G D,KARWI Q G,TIAN R,et al.Cardiac energy metabolism in heart failure[J].Circulation Research,2021,128(10):1487-1513.
[2] AMGALAN D,KITSIS R N.A mouse model for the most common form of heart failure[J].Nature,2019,568(7752):324-325.
[3] TSAO C W,ADAY A W,ALMARZOOQ Z I,et al.Heart disease and stroke statistics 2022 update:A report from the american heart association[J].Circulation,2022,145(8):e153-e639.
[4] WANG Q,LI C,ZHANG Q,et al.The effect of Chinese herbs and its effective components on coronary heart disease through PPARs-PGC1α pathway[J].BMC Complement Altern Med,2016,16(1):514.
[5] NOORDALI H,LOUDON B L,FRENNEAUX M P,et al.Cardiac metabolism-A promising therapeutic target for heart failure[J].Pharmacol Ther,2018,182(1):95-114.
[6] 张鹏,艾力曼?马合木提,孙娟.心肌能量代谢与慢性心力衰竭心室重构关系及心肌能量代谢药物应用的研究进展[J].中华实用诊断与治疗杂志,2018,32(1):94-97.
[7] 江佳林,陈梓欣,董鑫,等.益气活血法通过改善线粒体能量途径减轻缺血再灌注致心衰小鼠心肌纤维化[J].中华中医药杂志,2021,36(7):3967-3971.
[8] QIU Z,WEI Y,SONG Q,et al.The role of myocardial mitochondrial quality control in heart failure[J].Front Pharmacol,2019,10(1):1404.
[9] 刘莉,张君,邹国良,等.益气活血法对射血分数保留的心力衰竭患者临床疗效及左室质量指数的影响[J].辽宁中医杂志,2021,48(11):139-141.
[10] 杨向亚,李中瑞,张蕾.新活素联合补气强心汤方案干预急性心肌梗死并发心衰效果评价及减毒增效机制研究[J].中华中医药学刊,2021,39(8):189-192.
[11] 刘晓霞,王君,沈晓旭.益气活血法对舒张性心力衰竭气虚血瘀证患者的影响[J].中国医药导报,2021,18(7):117-121,135.
[12] 贺小芳,唐蓓蕾,王显,等.益气活血利水方治疗冠心病心力衰竭气虚血瘀水饮证患者疗效分析[J].现代中医临床,2020,27(3):9-12.
[13] 章轶立,李园,刘俊杰,等.基于生物分子网络的黄芪-丹参药对干预慢性心力衰竭作用机制预测研究[J].中国中医药信息杂志,2020,27(2):93-98.
[14] 刘静,徐江林,石晓路,等.益气活血法对舒张性心力衰竭大鼠心肌细胞钙稳态的影响[J].北京中医药大学学报,2022,45(2):165-175.
[15] 王臻,李洁白,董昕,等.补阳还五汤对舒张性心衰大鼠心肌α-MHC、β-MHC、Drp1 mRNA及线粒体超微结构的影响[J].北京中医药大学学报,2018,41(12):1002-1006.
[16] 庄杰钦,戴杏珍,金子淋,等.益气温阳活血利水法联合西医治疗急性心力衰竭疗效观察[J].中华中医药杂志,2021,36(2):1153-1156.
[17] 张和针,梁宇鹏,刘培中,等.真武汤合葶苈大枣泻肺汤治疗急性心力衰竭患者的临床观察[J].中国中医急症,2021,30(10):1793-1796.
[18] 景雅婷,王凤荣,刘月.温阳益心法联合西药治疗充血性心衰的临床疗效[J].河北医学,2019,25(8):1351-1356.
[19] 王成.温阳活血利水法对慢性心力衰竭患者心室重构的干预效应及机制探讨[J].中西医结合心脑血管病杂志,2018,16(20):3020-3023.
[20] 曹程浩,韩丽华,张会超.基于AMPK介导的线粒体自噬分析温阳益气方改善大鼠梗死后心衰的药理机制[J].中国比较医学杂志,2019,29(12):39-44.
[21] 邓子豪,赵含森.益气养阴祛痰利水法治疗慢性心力衰竭的疗效评价[J].中国社区医师,2022,38(31):74-76.
[22] 张宁,王新陆,王永霞.葶苈大枣泻肺汤治疗心力衰竭的理论与应用研究探讨[J].中医研究,2022,35(11):9-13.
[23] 王晓,杨永生.苓桂术甘汤合葶苈大枣泻肺汤治疗慢性心衰(痰饮阻肺型)临床疗效观察[J].甘肃科技,2019,35(22):132-134,168.
[24] 苏均.祛痰通阳汤联合盐酸贝那普利片治疗慢性心力衰竭气虚血瘀证临床分析[J].实用中医药杂志,2022,38(9):1591-1593.
[25] 贺晓芳,顾雄华,季菲.益气养阴化痰通络法治疗慢性心力衰竭的临床观察[J].中西医结合心脑血管病杂志,2015,13(17):1963-1965.
[26] 李志,吕梁川,张婷,等.强心化痰汤治疗慢性心力衰竭痰饮阻肺证30例临床观察[J].湖南中医杂志,2015,31(1):12-15.
[27] 纪红云,喻正科,成笑楠,等.基于数据挖掘探究中医药治疗射血分数保留性心力衰竭的用药规律[J].中医药临床杂志,2020,32(11):2104-2108.
[28] 李琳,曾逸笛,叶家豪,等.基于益气养阴法探讨参麦注射液调控肠道菌群-TMAO-炎症轴防治慢性心力衰竭的思路与策略[J].湖南中医药大学学报,2023,43(7):1258-1262.
[29] 荆亚倩,张贺芳,张庚良,等.养阴益气活血方治疗老年糖尿病心肌病合并心力衰竭疗效观察[J].现代中西医结合杂志,2023,32(6):802-805.
[30] 吕国芬,张振伟,郑岩磊,等.益气养阴活血方联合西药对慢性心力衰竭心肌纤维化患者心功能、心肌纤维化指标及炎症指标的影响[J].现代中西医结合杂志,2022,31(16):2269-2272.
[31] 张雪琰,于亚琳,郭瑞莹,等.益气养阴活血法治疗慢性心力衰竭疗效及安全性的系统评价[J].湖南中医杂志,2022,38(8):115-121,167.
[32] 李东军,黄明,周敏.益气养阴通脉汤联合美托洛尔对慢性心衰患者左室重塑及血管内皮细胞功能的影响[J].中药材,2021,44(11):2702-2706.
[33] 管慧,戴国华,高武霖,等.中医药干预对慢性心力衰竭合并心房颤动患者远期预后的影响[J].中华中医药杂志,2021,36(10):6086-6091.
[34] SHAOM W,LIF Y,LIH W.Traditional Chinese medicine enhances myocardial metabolism during heart failure[J].Biomed Pharmacother,2022,14(6):112538.
[35] SCHWEMMLEIN J,MAACK C,BERTERO E.Mitochondria as therapeutic targets in heart failure[J].Curr Heart Fail Rep,2022,19(2):27-37.

相似文献/References:

[1]杨禹娟,张勇,吕军,等.益气复脉注射液治疗老年冠心病并发慢性心力衰竭30例[J].陕西中医,2016,(10):1325.
 Yang Yujuan,Zhang Yong,Lv Jun,et al.[J].,2016,(7):1325.
[2]任红杰,赵安社,安谊沛,等.芪苈强心胶囊联合西药治疗慢性心力衰竭疗效及对患者NT-proBNP、hs-CRP、VEGF的影响*[J].陕西中医,2019,(6):711.
[3]樊一波,文颖娟△,李 蒙,等.以脾胃为中心的葛根相关配伍对糖尿病心肌病大鼠受损心肌线粒体的改善作用*[J].陕西中医,2020,(10):1351.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.002]
 FAN Yibo,WEN Yingjuan,LI Meng,et al.Improving effect of Pueraria-related compatibility centered on spleen and stomach on injured myocardial mitochondria in DCM rats[J].,2020,(7):1351.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.002]
[4]隋艳波,凌丽云,刘 莉.“血不利则为水”理论论治心力衰竭研究[J].陕西中医,2021,(2):213.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.019]
 SUI Yanbo,LING Liyun,LIU Li.Treating heart failure based on the theory of “Unsmooth blood circulation results in water”[J].,2021,(7):213.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.019]
[5]吴 鹏,邢俊娥,曹凌群,等.藿苓益智方对阿尔茨海默病模型小鼠神经细胞凋亡线粒体通路的作用研究[J].陕西中医,2021,(4):411.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.001]
 WU Peng,XING Jun'e,CAO Lingqun,et al.Study on the effect of Huoling Yizhi recipe on miton of mitochondria pathway of neuron apoptosis in Alzheimer's disease model mice[J].,2021,(7):411.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.001]
[6]陈仁山,肖惠珍,刘 宁,等.参芪扶正注射液抑制ERK1/2、GATA4信号通路改善小鼠心力衰竭实验研究[J].陕西中医,2022,(1):8.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.002]
 CHEN Renshan,XIAO Huizhen,LIU Ning,et al.Effect of Shenqi Fuzheng injection on heart failure in mice by inhibiting ERK1/2,GATA4 signaling pathway[J].,2022,(7):8.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.002]
[7]尼苦王康,邓 兵.中药治疗射血分数保留的心力衰竭研究进展[J].陕西中医,2022,(3):405.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.033]
 NiKU Wangkang,DENG Bing.Research progress of traditional Chinese medicine in treating heart failure with preserved ejection fraction[J].,2022,(7):405.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.033]
[8]董秀娟,曹若愚,于洪基,等.大蒜素对子宫内膜异位症大鼠异位病灶及缺氧诱导因子-1α表达的影响[J].陕西中医,2022,(4):432.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.005]
 DONG Xiujuan,CAO Ruoyu,YU Hongji,et al.Effects of Allicin on the ectopic lesions and the expression of HIF-1α in rats with endometriosis[J].,2022,(7):432.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.005]
[9]寇林利,赵明君,魏明明,等.苓桂术甘汤对慢性心力衰竭大鼠心肌功能及心室重构的影响[J].陕西中医,2022,(9):1170.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.004]
 KOU Linli,ZHAO Mingjun,WEI Mingming,et al.Effect on improvement of myocardial function and ventricular remodeling in rats with chronic heart failure by Linggui Zhugan decoction[J].,2022,(7):1170.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.004]
[10]周 媛,李启注,徐京育.苓桂术甘汤治疗心力衰竭研究进展[J].陕西中医,2022,(12):1819.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.042]
 ZHOU Yuan,LI Qizhu,XU Jingyu.Overview of the clinical application of Linggui Zhugan prescription in the treatment of heart failure[J].,2022,(7):1819.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.042]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金地区基金资助项目(82160887); 国家中医临床研究基地业务建设第二批科研专项课题(JDZX2015146); 国家中医药传承创新中心项目(2023019-10); 广西自然科学基金资助项目(2021GXNSFBA196018); 广西自然科学基金资助面上项目(2021GXNSFAA220111); 广西岐黄学者培养项目(2022015-003-02)
更新日期/Last Update: 2024-07-09